Original Article

Evaluation of Effects of the COVID-19 Crisis on Disease Management in Children with Type 1 Diabete

Abstract

Background: With the spread of the coronavirus disease 2019 (COVID-19), strict laws such as quarantine were implemented in many countries, including Iran. The spread of this disease and the general quarantine overshadowed the treatment and management of some chronic diseases, including type 1 diabetes, and many families faced a serious challenge in providing medicines and periodic tests for their children. This study was conducted with the aim of investigating the effects of the COVID-19 crisis on disease management in children with type 1 diabetes.

Method: Based on a researcher-made questionnaire, this cross-sectional study was conducted on 85 children with type 1 diabetes between the ages of 2 and 18 years in 6 months at the Children's Medical Center Hospital. This questionnaire is either collected from the parents during the face-to-face visit of the child with type 1 diabetes, or the virtual visit (telemedicine), and they were asked to complete the relevant questionnaire. This questionnaire included demographic information, laboratory tests, and the challenges of patients' families during the pandemic. In order to properly understand the management of this disease, parents were asked to enter the results of tests related to fasting blood sugar and HbA1c 3 times at the beginning of the pandemic, during quarantine, and during the implementation of the study.

Results: Based on the results, the level of HbA1c, the problem of insurance coverage, the problem of attendance, ketoacidosis, and infection before the pandemic, during the pandemic, and at the time of the study among children with type 1 diabetes were unchanged (P>0.05). There was a significant difference between fasting blood sugar levels, insulin levels, blood sugar control levels, and hospitalizations in type 1 diabetes patients before the pandemic, during the pandemic, and the study period (P<0.05).

Conclusion: Increasing the use of continuous glucose monitors and the widespread use of telemedicine visits may improve the impact of the pandemic on disease management. It is suggested that more multicenter studies with a higher sample size should be conducted in order to investigate the impact of the COVID-19 crisis on children with diabetes.

1. Arroyave F, Montaño D, Lizcano F. Diabetes Mellitus Is a Chronic Disease that Can Benefit from Therapy with Induced Pluripotent Stem Cells. Int J Mol Sci. 2020;21(22).
2. Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, et al. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Diabetes care. 2009;32(1):187-92.
3. Di Bartolo P, Nicolucci A, Cherubini V, Iafusco D, Scardapane M, Rossi MC. Young patients with type 1 diabetes poorly controlled and poorly compliant with self-monitoring of blood glucose: can technology help? Results of the i-NewTrend randomized clinical trial. Acta diabetologica. 2017;54:393-402.
4. Tai DBG, Shah A, Doubeni CA, Sia IG, Wieland ML. The disproportionate impact of COVID-19 on racial and ethnic minorities in the United States. Clinical infectious diseases. 2021;72(4):703-6.
5. Alqutob R, Al Nsour M, Tarawneh MR, Ajlouni M, Khader Y, Aqel I, et al. COVID-19 crisis in Jordan: Response, scenarios, strategies, and recommendations. JMIR public health and surveillance. 2020;6(3):e19332.
6. Rosenthal E. When high prices mean needless death. JAMA Internal Medicine. 2019;179(1):114-5.
7. Herkert D, Vijayakumar P, Luo J, Schwartz JI, Rabin TL, DeFilippo E, et al. Cost-related insulin underuse among patients with diabetes. JAMA Internal Medicine. 2019;179(1):112-4.
8. Al-Sofiani ME, Alyusuf EY, Alharthi S, Alguwaihes AM, Al-Khalifah R, Alfadda A. Rapid implementation of a diabetes telemedicine clinic during the coronavirus disease 2019 outbreak: our protocol, experience, and satisfaction reports in Saudi Arabia. Journal of diabetes science and technology. 2021;15(2):329-38.
9. Mann DM, Chen J, Chunara R, Testa PA, Nov O. COVID-19 transforms health care through telemedicine: evidence from the field. Journal of the American Medical Informatics Association. 2020;27(7):1132-5.
10. Betancourt JA, Rosenberg MA, Zevallos A, Brown JR, Mileski M, editors. The impact of COVID-19 on telemedicine utilization across multiple service lines in the United States. Healthcare; 2020: MDPI.
11. Khunti K, Aroda VR, Aschner P, Chan JCN, Del Prato S, Hambling CE, et al. The impact of the COVID-19 pandemic on diabetes services: planning for a global recovery. Lancet Diabetes Endocrinol. 2022;10(12):890-900.
12. Shi Y, Wu L-Q, Wei P, Liao Z-H. Children with type 1 diabetes in COVID-19 pandemic: difficulties and solutions. World Journal of Clinical Pediatrics. 2022;11(5):408.
13. Choudhary A, Adhikari S, White PC. Impact of the COVID-19 pandemic on management of children and adolescents with Type 1 diabetes. BMC pediatrics. 2022;22(1):124.
14. Conejero MS, de Buitrago Amigo JG, Bravo MLT, de Nicolás Jiménez JM. Impact of COVID-19 lockdown on glucemic control in children and adolescents with type 1 diabetes mellitus. Anales de Pediatría (English Edition). 2022;97(1):22-9.
15. Khunti K, Valabhji J, Misra S. Diabetes and the COVID-19 pandemic. Diabetologia. 2023;66(2):255-66.
16. Christoforidis A, Kavoura E, Nemtsa A, Pappa K, Dimitriadou M. Coronavirus lockdown effect on type 1 diabetes management οn children wearing insulin pump equipped with continuous glucose monitoring system. Diabetes research and clinical practice. 2020;166:108307.
17. Anjana RM, Pradeepa R, Deepa M, Jebarani S, Venkatesan U, Parvathi SJ, et al. Acceptability and utilization of newer technologies and effects on glycemic control in type 2 diabetes: lessons learned from lockdown. Diabetes Technology & Therapeutics. 2020;22(7):527-34.
18. Brener A, Mazor-Aronovitch K, Rachmiel M, Levek N, Barash G, Pinhas-Hamiel O, et al. Lessons learned from the continuous glucose monitoring metrics in pediatric patients with type 1 diabetes under COVID-19 lockdown. Acta diabetologica. 2020;57:1511-7.
Files
IssueVol 6, No 3 (2023) QRcode
SectionOriginal Article
DOI https://doi.org/10.18502/igj.v6i3.16574
Keywords
Coronavirus Diseases 2019 COVID-19 Type 1 Diabetes Telemedicine
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Khosh Nezhad Afkham E, Sayarifard F, Abbasi F, Rabbani A, Shabani H, Sayarifard A. Evaluation of Effects of the COVID-19 Crisis on Disease Management in Children with Type 1 Diabete. Immunol Genet J. 2023;6(3):103-107.